AXTOME
Axtome is an advertising company that offers innovative and customized digital billboards and signage.
AXTOME
Social Links:
Industry:
Advertising Digital Signage Outdoor Advertising
Founded:
2010-11-09
Address:
Marseille, Provence-Alpes-Cote D'Azur, France
Country:
France
Website Url:
http://www.axtome.com
Total Employee:
1+
Status:
Active
Contact:
04 91 81 00 82
Email Addresses:
[email protected]
Technology used in webpage:
Google Maps IPv6 ReCAPTCHA French Server Location
Similar Organizations
Colossal Media
Colossal Media is an outdoor advertising company that offers photorealistic murals, public art projects and commercial signage.
Bereik
Bereik is an advertising agency that helps brands to get audience with the help of digital screens and billboards for marketing campaigns.
Ecco
Ecco is an advertising company that offers signs, photo decks, stickers, window decor, street books, profile clothing and official stamps.
Frese Skyltar
Frese Skyltar is an advertising company that offers signs, laser engraving, information boards, digital print and film billboards.
Hageca
Hageca is an advertising company that offers neon signs, car lettering, billboards, facades, milling and engraving services.
MEDIALED
MEDIALED is an advertising firm that offers outdoor marketing, brand marketing, and digital signage services.
Primalinea
Primalinea is an advertising company that offers design and communication services such as exhibition stands and architectural spaces.
Splash
Splash is an advertising agency that focuses on outdoor advertising, banners and signage.
Official Site Inspections
http://www.axtome.com
- Host name: cluster010.hosting.ovh.net
- IP address: 213.186.33.19
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Axtome"
About Axsome - Axsome Therapeutics
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms …See details»
Axsome Therapeutics - Crunchbase Company Profile
Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of pain and other neurological diseases. By focusing on this therapeutic area, Axsome is addressing growing markets where …See details»
Axsome Therapeutics, Inc. | LinkedIn
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of ...See details»
Axsome Therapeutics, Inc. (AXSM) - Yahoo Finance
See the company profile for Axsome Therapeutics, Inc. (AXSM) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives ...See details»
Axsome Therapeutics Company Description - Stock Analysis
1 day ago Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in …See details»
About - HerriotTabuteauMD
Dr. Tabuteau is the principal scientist, founder, and CEO of Axsome Therapeutics, a New York City based biotechnology company focused on discovering and developing new medicines for …See details»
Axsome Therapeutics - Funding, Financials, Valuation & Investors
Axsome Therapeutics is registered under the ticker NASDAQ:AXSM . Their stock opened with $9.00 in its Nov 20, 2015 IPO. Axsome Therapeutics has acquired SUNOSI on May 28, ...See details»
Axsome Therapeutics Joins the Global Narcolepsy Community in …
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the …See details»
Axsome Therapeutics Annual Report 2021 - StockLight
AXSOME THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 45-4241907 (I.R.S. Employer …See details»
A Brief History of Axsome Therapeutics - CBM
Oct 2, 2024 Furthermore, Axsome Therapeutics is dedicated to fostering a culture of innovation and excellence within the organization. The company places a strong emphasis on recruiting …See details»
Axsome Therapeutics - Contacts, Employees, Board Members
Organization. Axsome Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... including Chief Executive Officer Herriot …See details»
AXSOME
American Headache Society (AHS) 2024 Annual Meeting . San Diego, California June 13-16, 2024See details»
Axsome Therapeutics Announces FDA Approval of AUVELITYâ„¢,
Aug 19, 2022 Axsome Contact: Mark Jacobson Chief Operating Officer Axsome Therapeutics, Inc. 22 Cortlandt Street, 16th Floor New York, NY 10007 Tel: 212-332-3243 Email: …See details»
Current Career Opportunities - Axsome Therapeutics
Axsome Therapeutics is seeking an experienced, dynamic commercial leader to manage the Trade and Distribution function and team. This individual will be responsible for the …See details»
Axsome Therapeutics Announces FDA Acceptance and Priority
Apr 26, 2021 FDA grants Priority Review and sets PDUFA action goal date of August 22, 2021 NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc....See details»
Axsome bounces back as FDA clears depression drug
2 days ago Axsome's drug was given a breakthrough designation from the FDA, reflecting the need for new treatment options in patients at increased risk of self harm or suicide, and was …See details»
Press Release Distribution and Management - GlobeNewswire
Total 3Q 2024 net product revenue of $104.8 million, representing 81% year-over-year growth Auvelity® 3Q 2024 net product sales of $80.4 million, representing 113% year-over-year …See details»
Axsome Therapeutics, Inc. (AXSM) - Yahoo Finance
Find the latest Axsome Therapeutics, Inc. (AXSM) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Patient Assistance Program Application Form
Axsome or Companies, or its and their agents or representatives, for prescribing an Axsome product. Version 1 August 2023 . Facility name Facility NPI HCP first name HCP NPI HCP last …See details»